DKSH signs exclusive partnership agreement with Eurodrug to provide high quality generic pharma products in Myanmar August 27, 2020


			
				DKSH signs exclusive partnership agreement with Eurodrug to provide high quality generic pharma products in Myanmar

DKSH has partnered with Eurodrug Laboratories Ltd., a Dutch pharmaceutical company that provides high quality, innovative and branded generic pharmaceutical products of European R&D. DKSH will market and distribute the company’s range of pharmaceutical products in Myanmar. 

Media release 

DKSH signs exclusive partnership agreement with Eurodrug to provide high quality generic pharma products in Myanmar

DKSH has partnered with Eurodrug Laboratories Ltd., a Dutch pharmaceutical company that provides high quality, innovative and branded generic pharmaceutical products of European R&D. DKSH will market and distribute the company’s range of pharmaceutical products in Myanmar. 

Yangon, Myanmar, August 27, 2020 – DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies seeking to grow their business in Asia, has partnered with Eurodrug Laboratories Ltd., a company dedicated to improving the health of people through the provision of pioneering pharmaceutical products. DKSH will manage the marketing and sales as well as logistics and distribution of Eurodrug products in Myanmar.

 

Eurodrug Laboratories is an international pharmaceutical company that has enabled healthcare professionals and their patients to have access to high quality, innovative and branded generic pharmaceutical products of European R&D in Asia, Eastern Europe/CIS and Latin America. Through this partnership, Eurodrugs aims to become a preferred pharma company for patients and doctors in Myanmar, providing safe and effective products.

 

With DKSH as a partner, Eurodrug can commercialize their products and build up its brand presence in Myanmar, an emerging market in their strongest region: Asia. The company can also tap into DKSH’s sales force as well as distribution channels to ensure that their pharmaceutical products reach patients across the country.

 

Eelco Broersma, CEO, Eurodrug Laboratories, said: “We are very excited about the collaboration of Eurodrug with DKSH. Both companies are well established in the Asian market with a rich history which will surely lead us to success in extending our business in Myanmar.”

 

Ankur Pandey, Vice President Healthcare, DKSH Myanmar, added: “We are proud to partner with a company that believes and supports in improving the health of people in our communities. With a proven track record in Myanmar and a strong organization with a long history, we are committed to driving growth for Eurodrug and improving access to healthcare products for all.”